Literature DB >> 1428212

Fast lysis by complement and uptake by liver of avidin-carrying biotinylated erythrocytes.

V R Muzykantov1, N Seregina, M D Smirnov.   

Abstract

The fate of 51Cr-labelled avidin-carrying biotinylated erythrocytes after intravenous injection in the rat was examined. Surface amino groups of the erythrocyte membrane were modified by biotin N-hydroxysuccinimide ester. The biodistribution and stability of biotinylated erythrocytes in the blood were similar to those of non-biotinylated cells. Both types of cells circulated in the bloodstream for prolonged periods of time without substantial lysis (about 2-3% of injected radioactivity per g of blood for 24-48 hours, no more than 2% of lysis). Both types of erythrocytes were cleared by the spleen. The clearance of biotinylated cells was faster and more pronounced (peak of spleen uptake at 3 hours after injection, up to 35% of injected radioactivity per g of spleen), than that of nonbiotinylated cells (peak of spleen uptake at 24 hours after injection, up to 25% of injected radioactivity per g of spleen). Attachment of avidin to biotinylated cells results in extremely rapid lysis and clearance from the bloodstream (0.17% of injected radioactivity per g of blood 30 min after injection, 100% lysis). Radioactivity was rapidly cleared by the liver (up to 80% of injected dose per g of tissue, 70% per organ). Uptake by the spleen plays only a minor role in the clearance. Considerable lung uptake of avidin-carrying biotinylated erythrocytes was observed. Avidin-carrying biotinylated erythrocytes were lysed by fresh homologous serum in vitro in contrast to biotinylated and native cells. Lysis was eliminated by pretreatment of serum with EDTA or heating, which indicates a complement-dependent mechanism of lysis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1428212

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  9 in total

Review 1.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 2.  Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond.

Authors:  Carlos H Villa; Douglas B Cines; Don L Siegel; Vladimir Muzykantov
Journal:  Transfus Med Rev       Date:  2016-08-17

Review 3.  Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.

Authors:  Patrick M Glassman; Elizabeth D Hood; Laura T Ferguson; Zongmin Zhao; Don L Siegel; Samir Mitragotri; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2021-09-29       Impact factor: 15.470

4.  Cyclic arginine-glycine-aspartic acid-modified red blood cells for drug delivery: Synthesis and in vitro evaluation.

Authors:  Chen Wang; Min Wang; Yan Zhang; Hongxin Jia; Binbin Chen
Journal:  J Pharm Anal       Date:  2021-06-12

5.  Development and evaluation of anti-malarial bio-conjugates: artesunate-loaded nanoerythrosomes.

Authors:  Jaya Agnihotri; Shubhini Saraf; Sobhna Singh; Papiya Bigoniya
Journal:  Drug Deliv Transl Res       Date:  2015-10       Impact factor: 4.617

Review 6.  Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier.

Authors:  Carlos H Villa; Daniel C Pan; Sergei Zaitsev; Douglas B Cines; Donald L Siegel; Vladimir R Muzykantov
Journal:  Ther Deliv       Date:  2015-07

7.  Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor.

Authors:  A B Zaltzman; C W Van den Berg; V R Muzykantov; B P Morgan
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

8.  Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells.

Authors:  Aaron C Anselmo; Vivek Gupta; Blaine J Zern; Daniel Pan; Michael Zakrewsky; Vladimir Muzykantov; Samir Mitragotri
Journal:  ACS Nano       Date:  2013-11-12       Impact factor: 15.881

9.  The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells.

Authors:  Daniel Pan; Omayra Vargas-Morales; Blaine Zern; Aaron C Anselmo; Vivek Gupta; Michael Zakrewsky; Samir Mitragotri; Vladimir Muzykantov
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.